Hillhouse Investment Group

Hillhouse Investment Group, established in 2005 and headquartered in Hong Kong, is a prominent global investment management firm that focuses on private equity. The firm engages in long-term investments across various sectors, including healthcare, business services, consumer goods, industrials, and energy transition. Hillhouse partners with exceptional entrepreneurs to foster sustainable value creation within quality companies. In addition to private equity, the firm also participates in public equity, real estate, and private credit, managing capital on behalf of global institutions such as non-profit foundations, endowments, and pension funds.

Joe Gagnon

Partner

Huang Liming

Partner

David Rhee

Partner

Michael Yi

Partner

Sean Carney

Partner and Co-Head of Global Buyout

Past deals in Asia

Xiaohongshu

Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.

GDS International

Post in 2024
GDS International portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia (Johor), Indonesia (Batam), and Japan (Tokyo).

Astronergy

Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.

Core Medical Technology

Series C in 2022
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

ZCOOL

Series C in 2022
ZCOOL is an online community platform founded in August 2006 in Beijing, designed for designers to showcase their graphic designs and connect with potential commercial opportunities. With over four million users and approximately 20,000 design works uploaded daily, the platform facilitates the sharing and display of creative work. ZCOOL collaborates with Shutterstock to enhance its image database services, further enriching the offerings for its users. The company aims to leverage recent funding to expand its community, strengthen content, and provide additional services, including training courses and job matching to support its members in their professional development.

CenoBots (Cenozoic Robotics)

Series A in 2022
Cenozoic Robotics is a global leading provider for the cleaning industry. Founded in 2021, Cenozoic Robotics is headquartered in Singapore with offices in Hong Kong and Hangzhou. Employing knowledge and experience in L4 autonomous driving technology, the Cenozoic team realized the potential to provide customers with faster service and higher quality products than currently on the world market. With this goal in mind, Michael Wang, the founder and the CEO of Cenozoic Robotics, and his team established the company and entered the cleaning industry dedicated to renewing cleaning services with state-of-the-art technologies. Up to now, Cenozoic robots have been deployed at multiple sites in Singapore, Japan, and South Korea.

GritWorld

Series B in 2022
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

EPiCMEMS

Series A in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.

XVERSE

Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

SceneRay

Series D in 2022
SceneRay Co. Ltd, based in Singapore Industrial Park, Suzhou, China, specializes in the design, development, and distribution of neuromodulation devices, particularly focusing on brain pacemakers. The company’s core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. SceneRay's product offerings include a dual-channel implantable pulse generator kit designed for deep brain stimulation, which provides therapeutic electric stimulation to address issues related to brain damage. Committed to innovation, SceneRay holds numerous patents and strives to deliver high-quality, effective treatments for patients.

Harmay

Series D in 2022
Harmay is a retailer based in China that specializes in premium cosmetics and beauty products. The company focuses on contemporary fashion and aesthetics, aiming to convey the concept of beauty and an enriched lifestyle. Harmay offers a diverse range of well-known international cosmetics and skincare brands, alongside its own self-developed personal skincare products. By targeting urban dwellers, Harmay provides high-quality makeup and cosmetics that resonate with modern beauty standards.

Westlake Omics

Seed Round in 2022
Westlake Omics is a biotechnology company based in Hangzhou, Zhejiang, China, founded in 2020. It specializes in mass spectrometry-based proteomics and other Omics technologies to meet critical clinical needs. The company aims to advance precision medicine and drug research and development by utilizing artificial intelligence for high-throughput proteomic analysis of small clinical specimens. Through its innovative approach, Westlake Omics focuses on enhancing the accuracy of tumor diagnosis and developing reliable, cutting-edge products that address significant health challenges. By integrating technological advancements and multi-modal big data, the company is dedicated to making meaningful contributions to the field of clinical diagnostics.

UWinTech

Series C in 2022
UWinTech is a comprehensive provider of IT operations and maintenance solutions, established in 2015 and headquartered in Shenzhen, China. The company specializes in application management services that encompass continuous delivery, continuous deployment, operation automation, and application monitoring. Its product offerings include EasyCMDB, Easydevops, Easyobserve, EasyMAbuilder, and Easyautoops. By delivering these integrated services, UWinTech aims to assist enterprises in streamlining their IT operations, thereby reducing operational efforts and enhancing productivity.

Thousand Oaks Biopharmaceuticals

Venture Round in 2021
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.

NASN Automotive Electronics

Series C in 2021
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company offers a range of products, including the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. By focusing on research and development, production, and sales, NASN aims to provide advanced and comprehensive solutions that enhance vehicle safety and intelligence, catering to the growing demand for innovative automotive technologies in China.

Great Bay Bio

Series A in 2021
Great Bay Bio Ltd. is a biotechnology company based in Central Hong Kong, founded in 2002. The company specializes in drug discovery and contract research services, leveraging artificial intelligence within its Chemistry, Manufacturing, and Control (CMC) platform to enhance drug development processes. Great Bay Bio is involved in the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. With a focus on biopharmaceutical innovation, the company utilizes a digital platform that integrates AI technology, big data, and Internet of Things technology to streamline the drug development cycle and reduce costs. By aligning with national strategies for scientific innovation and fostering collaboration across regions such as Europe, the United States, Singapore, and Hong Kong, Great Bay Bio aims to enhance its competitive edge in the biopharmaceutical industry.

Hesai Technology

Series D in 2021
Hesai Technology is a company based in Shanghai, China, founded in 2014. It specializes in designing laser radar systems using smart sensing technology. The primary application of these systems is to facilitate autonomous driving by enabling car companies to monitor mixed gas composition and detect hazardous leaks. Additionally, Hesai Technology develops natural gas leak detection systems for industrial processes. Its LiDAR products are used in a variety of applications including advanced driver assistance systems (ADAS), autonomous vehicle fleets, last-mile delivery robots, street sweeping robots, and logistics robots. The company operates through two main segments: the LiDAR segment and the gas detection segment, with the former being the primary revenue generator.

GritWorld

Series B in 2021
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

Js Designs

Series A in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.

Js Designs

Series B in 2021
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources, one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed.

HeyTea

Series D in 2021
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.

GRIT Biotechnology

Series A in 2021
GRIT Biotechnology is a research and development company based in Shanghai, China, focusing on tumor infiltration lymphocytes (TIL) immunotherapy for the treatment of solid tumors. Founded in 2019, the company is dedicated to advancing the field of immunotherapy with the aim of enhancing the effectiveness of tumor treatments. By leveraging innovative approaches in TIL technology, GRIT Biotechnology seeks to provide new therapeutic options for patients battling solid tumors.

Market Kurly

Series F in 2021
Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies. Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottled water, condiments such as flour & salt, processed foods, and more. The company was founded in 2015 and based in Seoul, South Korea.

XVERSE

Angel Round in 2021
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

Hetao101

Series C in 2021
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Kelun Biotech

Funding Round in 2021
Kelun Biotech is an innovative biopharmaceutical company based in China, dedicated to the research, development, production, and commercialization of novel drugs. With over a decade of experience, the company has established itself as a pioneer in the development of antibody-drug conjugates (ADCs). Kelun Biotech adopts a systematic and indication-oriented strategy, focusing on prevalent and challenging cancers as well as other medical conditions affecting large, underserved populations. Its commitment to addressing significant medical needs positions the company as a key player in the global biopharmaceutical landscape.

XAG

Series C in 2021
XAG Co., Ltd., established in 2007 and headquartered in Guangzhou, China, specializes in the design and manufacture of drones, robots, autonomous driving solutions, and AI-based equipment tailored for the agricultural industry. The company's product portfolio includes unmanned aerial vehicles (UAVs) for recreational and commercial use, ranging from hobbyist model aircraft to large-scale professional UAVs for various applications such as aerial imaging, monitoring, lifting, and logistics. XAG's offerings also extend to commercial and industrial products and services, which are employed in low-altitude airspace logistics, police and medical assistance, fire prevention, geological prospecting, surveying, and arctic expeditions.

Cryofocus Biotech

Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

Innocare

Post in 2021
InnoCare is a biopharmaceutical company based in China, focused on discovering, developing, and commercializing innovative treatments for cancer and autoimmune diseases. The company boasts a skilled scientific team with extensive experience in drug innovation from both the U.S. and China, supported by an accomplished Scientific Advisory Board comprised of experts from prominent universities, hospitals, and the pharmaceutical sector. InnoCare's product pipeline includes several key therapies, such as orelabrutinib, ibrutinib, zanubrutinib, and tafasitamab, targeting hematological tumors, solid tumors, and autoimmune disorders. The company is also dedicated to addressing autoimmune diseases linked to abnormal B-cell or T-cell functions, positioning itself as a leader in advancing medical treatments and tackling complex health challenges.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Lalamove

Series F in 2021
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

Targeting One

Series B in 2021
Beijing Targeting One Technology Co., Ltd. specializes in the development and production of biomedical instruments and consumables, focusing on in vitro diagnostic reagents for precision medicine, health management, and life science research. Established in 2015 and based in Beijing, the company offers a range of products including sample preparation apparatus, biochip readers, digital PCR supplies, and genetic testing kits. Its digital PCR solutions play a crucial role in medical diagnostics, with applications in transplant rejection monitoring, targeted sequencing, tumor liquid biopsy, and non-invasive prenatal screening. Targeting One aims to enhance gene testing and precision medicine through its innovative technologies and comprehensive offerings.

ICAN Technology

Seed Round in 2021
Beijing ICAN Technology Co. Ltd. is a leading weather station operation company that specializes in developing a big data, information, and analytics platform tailored for agriculture. Founded in 2016, the company offers comprehensive services that integrate weather, soil data, local crop management practices, and pest information. ICAN Technology's systems include a robust database, statistical software, and an Internet of Things framework, facilitating real-time data collection through agricultural weather stations and field imaging. The company is also involved in seed production and breeding services, leveraging expertise from its founders and research center, which focuses on advanced plant growth and weather forecasting models. With over 100 private weather stations across China, ICAN Technology serves major seed companies, employing a unique business model aimed at profitability.

Delivery Hero

Post in 2021
Delivery Hero is a global network of online food ordering platforms, operating in 21 countries and partnering with over 73,000 restaurants. The company has a significant presence in various markets, including Germany, the UK, South Korea, and several Latin American countries. With a workforce of more than 1,000 employees, around 400 of whom are based at its headquarters in Berlin, Delivery Hero has established itself as a key player in the food delivery industry. The company has attracted substantial investment, securing $523 million in 2014 from various investors, which has helped it expand its reach and capabilities in the competitive online food delivery market.

Core Medical Technology

Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

ImmVira

Series C in 2020
Immvira, founded in Shenzhen, China, in May 2015 by a group of prominent professors from various universities, is focused on developing biopharmaceutical technology in the field of immunotherapy. The company specializes in creating oncolytic viruses and vector-type approaches aimed at treating cancer. Its primary product is a genetically engineered Oncolytic Herpes Simplex Virus, which is designed to target metastatic tumors or tumors that are difficult to access by direct injection. By leveraging this innovative technology, Immvira aims to provide more effective treatment solutions for patients suffering from cancer.

Lalamove

Series E in 2020
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

DEEPEXI

Series A in 2020
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

MicroPort MedBot

Private Equity Round in 2020
MicroPort MedBot, headquartered in Shanghai, China, is a leading company in the field of surgical robotics, focusing on the design, development, and commercialization of advanced surgical solutions. The company specializes in intelligent surgical systems that cater to the clinical needs of minimally invasive surgery, utilizing technologies such as smart robotics, intelligent control, and information sensing. Its product portfolio includes 3D electronic laparoscopy systems, laparoscopic surgical robots, and orthopedic surgical robots, which are aimed at assisting surgeons in executing complex procedures more efficiently. MicroPort MedBot derives the majority of its revenue from the Chinese market, with additional business activities in the United States and Europe.

I-Mab Biopharma

Post in 2020
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.

Yuanfudao

Series G in 2020
Yuanfudao, founded in 2012, is the largest online live course platform in China, catering to primary and secondary school students. With over 1 million paying users, it provides a comprehensive curriculum that includes subjects such as English, Mathematical Olympiad, and various all-subject courses for secondary education. The platform features live online tutoring conducted by nationally recognized teachers, allowing students to receive quality education from home. By utilizing big data analysis, Yuanfudao enables students to identify their learning weaknesses and engage in targeted learning, thus enhancing their educational outcomes. The combination of its extensive course offerings and a large pool of qualified educators benefits hundreds of thousands of students across the country.

JD.com

Series B in 2020
JD.com, Inc., based in Beijing, is a leading e-commerce company in China, operating through its subsidiaries. It offers a wide array of products, from electronics and apparel to food and healthcare items, through its website and mobile apps. JD.com is notable for its extensive logistics network, JD Logistics, which provides efficient and reliable delivery services. The company also operates JD Health, a prominent online healthcare platform offering pharmaceuticals, medical supplies, and online consultations. JD.com's unique selling proposition lies in its self-operated logistics network, ensuring speedy and reliable delivery, and its commitment to providing authentic products. As of 2022, JD.com's gross merchandise volume (GMV) was comparable to Pinduoduo's, but still lower than Alibaba's.

Xpeng Motors

Series C in 2020
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.

Antengene

Series C in 2020
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016, that specializes in the development of innovative therapies for cancer treatment. The company's portfolio includes ATG-010 (selinexor), targeting hematologic malignancies such as multiple myeloma, and ATG-008 (onatasertib), an mTOR kinase inhibitor aimed at treating advanced solid tumors and hematological malignancies. Antengene's pipeline features several investigational products, including ATG-016 (eltanexor), ATG-527 (verdinexor), and ATG-019, along with pre-clinical candidates like ATG-101, a bi-specific antibody, and ATG-012, a KRAS G12C inhibitor. The company is committed to addressing unmet medical needs in Asia through its focus on the discovery, development, and commercialization of first-in-class therapeutics for various types of cancer.

Joincare Pharmaceutical

Post in 2020
Joincare Pharmaceutical Industry Group Co., Ltd (hereinafter called Joincare Pharmaceutical Group), growing out of Shenzhen Taitai Healthcare Food Co., Ltd, was established by the board chairman Zhu Baoguo in the year 1992. The leading position in the healthcare industry was established by “Taitai Oral Liquid”. The strategy of the company was in transition to enter pharmaceutical industry in 1995, and was renamed Shenzhen Taitai Pharmaceutical Co., Ltd. This transformation was successfully completed by the acquisition of Shenzhen Haibin Pharmaceutica Co., Ltd in 1997. In 1999, the company was renamed Shenzhen.

BeiGene

Post in 2020
BeiGene, Ltd. is a global biotechnology company founded in 2010, focused on the discovery and development of innovative oncology treatments aimed at improving accessibility and affordability for cancer patients worldwide. Based in Beijing, with a presence in the United States and beyond, BeiGene has established one of the largest oncology research teams globally, employing over 9,200 professionals. The company’s commercial portfolio includes BRUKINSA, a BTK inhibitor approved for various blood cancers, and Tislelizumab, an anti-PD-1 antibody currently under regulatory review for advanced esophageal squamous cell carcinoma. BeiGene's extensive pipeline encompasses a wide range of cancer therapies targeting multiple malignancies, including acute myeloid leukemia, multiple myeloma, and solid tumors. In addition to its therapeutic development, the company actively engages in programs that address the broader needs of oncology patients, such as mental health awareness initiatives. Through its commitment to innovation and patient care, BeiGene aims to significantly impact cancer treatment and improve outcomes for patients around the globe.

Narwal Robotics

Series C in 2020
Narwal Robotics focus on design, development, and production of intelligent cleaning robots.

Global Data Solutions

Post in 2020
Global Data Solutions Limited is a data center operator based in Shanghai, China, with additional facilities in Beijing, Chengdu, Shenzhen, Kunshan, and Guangzhou. Founded in 2000 by William Wei Huang, the company specializes in designing, building, and managing data centers, providing services such as colocation, managed hosting, and managed cloud solutions. It offers information technology outsourcing services, including business continuity and disaster recovery, which encompass planning, design, implementation, and operation. The company primarily serves clients in the Internet and banking sectors, as well as a range of industries including finance, energy, manufacturing, aviation, telecommunications, and large corporations, both domestic and multinational. Global Data Solutions aims to deliver high-quality infrastructure and support to enhance operational efficiency and reliability for its diverse customer base across the Asia-Pacific region.

Everest Medicines

Series C in 2020
Everest Medicines Limited is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2017. The company focuses on licensing, developing, and commercializing innovative therapies to meet critical unmet medical needs in Greater China and other Asia Pacific markets. Its diverse portfolio includes eight clinical-stage drug candidates aimed at treating various conditions such as oncology, immunology, cardio-renal diseases, and infectious diseases. Everest Medicines aims to partner with innovative global companies to bring transformative pharmaceutical solutions to the Emerging Market, leveraging its expertise in clinical development, regulatory affairs, and business operations. The company's pipeline features several notable candidates, including Nefecon, EVER001, PTX-COVID19-B, and Eravacycline, among others.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.

DEEPEXI

Series A in 2020
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

ASR Microelectronics

Series D in 2020
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.

MicroPort CardioFlow

Private Equity Round in 2020
Shanghai MicroPort CardioFlow Medtech Co., Ltd., established in 2015, is a medical device company specializing in advanced minimally invasive therapies for structural heart diseases. As a subsidiary of MicroPort Scientific Corporation, it focuses on the research, development, and commercialization of innovative solutions for valvular heart diseases. The company's product portfolio includes VitaFlow, VitaFlow Liberty, Alwide Plus, and a range of transcatheter aortic valve implantation (TAVI), transcatheter mitral valve (TMV), and surgical valve products, along with procedural accessories. Primarily operating in China, MicroPort CardioFlow emphasizes the importance of improving patient quality of life through reliable and affordable healthcare solutions while maintaining a global vision for its products and services.

Market Kurly

Series E in 2020
Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies. Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottled water, condiments such as flour & salt, processed foods, and more. The company was founded in 2015 and based in Seoul, South Korea.

Suzhou Ribo Life Science

Series C in 2020
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.

Yuanfudao

Series G in 2020
Yuanfudao, founded in 2012, is the largest online live course platform in China, catering to primary and secondary school students. With over 1 million paying users, it provides a comprehensive curriculum that includes subjects such as English, Mathematical Olympiad, and various all-subject courses for secondary education. The platform features live online tutoring conducted by nationally recognized teachers, allowing students to receive quality education from home. By utilizing big data analysis, Yuanfudao enables students to identify their learning weaknesses and engage in targeted learning, thus enhancing their educational outcomes. The combination of its extensive course offerings and a large pool of qualified educators benefits hundreds of thousands of students across the country.

HeyTea

Series D in 2020
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.

IASO Biotherapeutics

Series B in 2020
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company established in 2017 and located in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies aimed at treating cancer. IASO Biotherapeutics is particularly focused on engineered autologous and allogenic T cell therapies, which are designed to enhance the immune system's capability to identify and eliminate cancer cells. Through its research and development efforts, the company aims to provide effective cancer treatments that leverage the body's own immune response.

CCC Information Services

Series A in 2020
CCC Information Services, established in 2010 and based in Beijing, China, specializes in developing machine learning and AI technologies for the automotive aftermarket and insurance sectors. The company offers accident repair programs and serves mid-to-downstream service providers, including large and medium-sized insurance companies, automobile dealer groups, and maintenance chain companies.

Ke.com

Series D in 2020
Beike (www.ke.com) was founded in early 2018, China's newest, smartest and technology-driven multi-service property platform, designed to improve user experience and increase exposure for our trusted partners at the same time. Beike is an open platform and enables excellent agents to use resources more effectively, together to be a high-quality ecosystem of second-hand property, new property, rental property and decoration on the one hand. On the other, All accredited partners through providing high-quality housing and technical support, and partner could apply to be a franchisee. In the following several years, Beike aims to cover over 300 cities in China and franchise more than 100 partners, linking 100 thousand branches and 1 million property agents and serving over 200 million households. Beike Overseas was designed to meet the needs for the growing number of Chinese families seeking overseas property, including new property, secondhand property, and rental property. Beike overseas now covers 11 countries, the U.S., Canada, Australia, New Zealand, the U.K., France,Germany, Singapore, Japan, Thailand, and Korea, and has over 10,000 listings online.

eRoad Software

Series C in 2020
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated Mobile and Employee Services platform, with a particular emphasis on payroll solutions tailored for mid-to-large sized enterprises. Its innovative "HR+ business data" model enables organizations to analyze human effectiveness and cost efficiency, thereby enhancing operational efficiency and improving business insights. The platform supports the entire employee lifecycle, encompassing functions such as recruiting, onboarding, payroll management, benefits administration, workforce management, performance management, and talent management, making it a comprehensive solution for organizations seeking to optimize their human resource processes.

GritWorld

Series A in 2019
GritWorld GmbH specializes in designing and developing advanced real-time graphics and large-scale 3D reconstruction software solutions. Founded in 2015 and headquartered in Frankfurt am Main, Germany, with additional offices in Shanghai and Guangzhou, the company offers a range of products including GritRena, which reconstructs 3D models from 2D photos, GritVis, a suite of cinematic tools for game engines, and SmartCity, a platform for visualizing urban information in 3D. GritWorld aims to enhance the efficiency and quality of real-time data simulation and visualization across various industries, including entertainment, urban management, and industrial applications. By facilitating the transition from standard data formats to high-quality graphical representations, GritWorld aids in the digital transformation of businesses, promoting advancements in computer graphics, virtual reality, and augmented reality technologies.

Elpiscience Biopharmaceuticals

Series B in 2019
Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Harmay

Series A in 2019
Harmay is a retailer based in China that specializes in premium cosmetics and beauty products. The company focuses on contemporary fashion and aesthetics, aiming to convey the concept of beauty and an enriched lifestyle. Harmay offers a diverse range of well-known international cosmetics and skincare brands, alongside its own self-developed personal skincare products. By targeting urban dwellers, Harmay provides high-quality makeup and cosmetics that resonate with modern beauty standards.

Lima Technology

Series A in 2019
Beijing Lima Technology Co., Ltd. is a cloud-based Software-as-a-Service (SaaS) provider specializing in solutions for insurance brokers and sales agencies. Founded in 2017 and headquartered in Beijing, the company develops an intelligent hub within the insurance supply chain, offering targeted software solutions that enhance operational efficiency. Its offerings include mobile exhibition industry solutions, enterprise management, business operations, and financial settlement solutions. Lima Technology leverages advanced technologies such as artificial intelligence and big data to support digital transformation in the insurance sector, enabling sales agencies of various sizes to streamline their operations and implement self-service sales experiences. The company focuses on facilitating the digitization and intelligence of insurance sales processes while maintaining a commitment to innovation and reliability in its technical support.

HuidaGene Therapeutics

Series A in 2019
HuidaGene Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2018. The company specializes in the research and development of gene therapies for single-gene disorders and is expanding its focus to neurodegenerative diseases and vision disorders. HuidaGene employs its proprietary CRISPR-based and AI-driven HG-PRECISE platform to create potentially curative therapies. Among its clinical programs, HuidaGene is advancing HG004 for RPE65-associated retinal disease, HG202 for neovascular age-related macular degeneration, HG204 for MECP2 duplication syndrome, and HG302 for Duchenne muscular dystrophy. Several of these therapies have received orphan drug designations and rare pediatric disease designations from regulatory authorities. In addition to its clinical initiatives, the company is exploring preclinical programs, including HG303 for amyotrophic lateral sclerosis and a CRISPR RNA-editing therapy for Alzheimer’s disease.

Boke Software

Series B in 2019
Boke Information Co., Ltd. specializes in the research and development of management software and offers management consultancy services in China. The company focuses on creating logistics management solutions that enhance supply chain efficiency through the application of artificial intelligence and machine learning technologies. Boke provides implementation and maintenance services for its software products, catering to various enterprises, government entities, and community organizations. Its innovative approach emphasizes personalized software solutions designed for autonomous configuration, self-expansion, and autonomous maintenance. By supporting clients throughout the entire lifecycle of their IT systems, Boke assists in establishing comprehensive organizational frameworks and ecological structures tailored to their specific needs.

Gree Electric Appliances

Post in 2019
Gree Electric Appliances, Inc. of Zhuhai is a leading manufacturer of household appliances and industrial equipment, primarily known for its extensive range of air conditioning products. Established in 1989 and headquartered in Zhuhai, China, the company offers a diverse portfolio that includes residential and commercial air conditioners, air-to-water heat pumps, and various home appliances such as electric fans, heaters, water purifiers, and multi-cookers. Gree has evolved into a technologically advanced industrial production group, focusing on both domestic consumer goods and industrial equipment. The company generates a significant portion of its sales within China, with air conditioning systems accounting for a major share of its revenue. Additionally, Gree has expanded into sectors such as industrial components, photovoltaic equipment, and new energy vehicles, underscoring its commitment to innovation and diversification in the appliance industry.

Kujiale

Series D in 2019
Kujiale is a Chinese-based online platform specializing in home decoration and furnishing information. Founded by Hang Chen and headquartered in Hangzhou, the company offers business reviews and facilitates design processes through advanced tools such as 3D modeling, texture swapping, and floor planning software. Users can visualize designs in various formats like 360-degree views, augmented reality, photo-realistic rendering, or virtual reality to make informed decisions about their home decor choices.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Hetao101

Series B in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Golden Technology

Series B in 2019
Golden Technology is a big data service company based in China that specializes in providing electronic invoicing solutions through blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform designed to serve various sectors, including grocery retailers, parking lots, and restaurants. Its platform offers a range of services such as electronic invoicing, reimbursement, record-keeping, and transaction inspection and management. By leveraging blockchain, Golden Technology aims to provide convenient and cost-effective alternatives to traditional paper-based receipts, enhancing the efficiency and transparency of financial transactions.

Fapiaoer

Series B in 2019
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.

DEEPEXI

Series A in 2019
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Perfect Diary

Series C in 2019
Perfect Diary is an e-commerce-based cosmetic brand. The company is committed to exploring the trends in international cosmetics and the frontiers of fashion to provide easy-to-use cosmetics products for young Asian women.Perfect Diary is professional in branding and online traffic management. By launching co-branded cosmetic products with KOLs, idols and even some famous organizations like the British Museum

Aier Eye Hospital Group

Post in 2019
Aier Eye Hospital Group Co., Ltd. is a prominent provider of eye care services, operating a network of approximately 200 ophthalmic hospitals in mainland China, along with additional facilities in Europe, the United States, and Hong Kong. Established in 2007 and headquartered in Changsha, China, the company specializes in a range of ophthalmic treatments, including myopia surgery, cataract and glaucoma management, pediatric ophthalmology, and corneal diseases. It also offers optometry services and training courses focused on cataract prevention and treatment. Aier Eye Hospital Group is dedicated to delivering high-standard medical care and advancing ophthalmic technology and management practices in the region.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

Ke.com

Series D in 2019
Beike (www.ke.com) was founded in early 2018, China's newest, smartest and technology-driven multi-service property platform, designed to improve user experience and increase exposure for our trusted partners at the same time. Beike is an open platform and enables excellent agents to use resources more effectively, together to be a high-quality ecosystem of second-hand property, new property, rental property and decoration on the one hand. On the other, All accredited partners through providing high-quality housing and technical support, and partner could apply to be a franchisee. In the following several years, Beike aims to cover over 300 cities in China and franchise more than 100 partners, linking 100 thousand branches and 1 million property agents and serving over 200 million households. Beike Overseas was designed to meet the needs for the growing number of Chinese families seeking overseas property, including new property, secondhand property, and rental property. Beike overseas now covers 11 countries, the U.S., Canada, Australia, New Zealand, the U.K., France,Germany, Singapore, Japan, Thailand, and Korea, and has over 10,000 listings online.

eRoad Software

Series C in 2019
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated Mobile and Employee Services platform, with a particular emphasis on payroll solutions tailored for mid-to-large sized enterprises. Its innovative "HR+ business data" model enables organizations to analyze human effectiveness and cost efficiency, thereby enhancing operational efficiency and improving business insights. The platform supports the entire employee lifecycle, encompassing functions such as recruiting, onboarding, payroll management, benefits administration, workforce management, performance management, and talent management, making it a comprehensive solution for organizations seeking to optimize their human resource processes.

Jinxin Fertility

Series F in 2019
Jinxin Fertility Group Limited is a prominent provider of assisted reproductive services (ARS) with operations in China and the United States. Established in 2003 and headquartered in Chengdu, China, the company offers various treatment options, including artificial insemination with either the patient's or donor's sperm and in vitro fertilization (IVF) techniques, such as conventional IVF and intracytoplasmic sperm injection (ICSI). In addition to reproductive services, Jinxin Fertility provides complementary offerings like nutrition guidance, Chinese medicine treatment, and psychological counseling to enhance patient support. The company operates several subsidiaries, including Chengdu Xinan and Shenzhen Zhongshan, as well as HRC in the United States, thereby expanding its network and service capabilities. Jinxin Fertility's commitment to high-quality care and innovative reproductive solutions has positioned it as a leader in the field.

Market Kurly

Series D in 2019
Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies. Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottled water, condiments such as flour & salt, processed foods, and more. The company was founded in 2015 and based in Seoul, South Korea.

Yunshuxie

Series B in 2019
Yunshuxie is a provider of comprehensive reading and writing solutions tailored for K-12 students in China. The company operates an online platform that archives and organizes a wide range of Chinese literature, creating a structured curriculum to enhance students' reading and writing skills. By integrating offline classroom experiences with online reading clubs, Yunshuxie delivers a holistic approach to literature education, serving over 2 million students. The platform is designed to facilitate both learning and practice in Chinese literature, ensuring that students have access to systematic and complete educational resources.

DEEPEXI

Seed Round in 2019
DEEPEXI, officially known as Beijing Dip Technology Co., Ltd., is a prominent player in the digital transformation sector for enterprises. Established in May 2018 and headquartered in Beijing, the company has grown to employ around 160 staff members, with significant research and development capabilities concentrated in its branches across major cities like Guangzhou, Shenzhen, Nanjing, and Chengdu. DEEPEXI specializes in providing scalable business intelligence services that leverage a cloud-native Internet framework, integrating advanced technologies such as 5G, IoT, big data, AI, and cloud computing. This enables businesses to enhance their decision-making and strategic initiatives through data intelligence. The company prides itself on having a highly skilled R&D team, which includes leading experts in artificial intelligence and open-source projects.

Huolala

Series D in 2019
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services. Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.

Lalamove

Series D in 2019
Lalamove, originally known as EasyVan, was established in Hong Kong in December 2013 to address the demand for efficient van hire services. The company operates in 21 markets across Asia and Latin America, connecting over 7 million customers with a network of more than 700,000 driver-partners. Lalamove's on-demand logistics platform facilitates instant matching between customers and drivers, enabling same-day deliveries with an impressive average fulfillment time of just 55 minutes. The platform offers van-hailing and courier services, allowing customers to track their deliveries in real time and rate their drivers. By optimizing routes and fleets, Lalamove enhances the earning potential for drivers while providing reliable and swift delivery solutions for businesses and individuals alike.

Hetao101

Series A in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Hetao101

Series A in 2019
Hetao101, also known as Walnut Coding, is a Beijing-based children's edtech company that focuses on providing programming education for children aged four to twelve. Founded in 2017, the company offers an AI-driven online platform and smart products designed to enhance children's logical thinking and programming skills. With a team of over 400 tutors, Hetao101 develops a specialized curriculum aligned with the Computer Science Teachers Association (CSTA) teaching standards. This curriculum emphasizes programming skill development, aiming to prepare students for higher education and foster an interest in computer science.

Woowa Bros

Series G in 2018
Woowa Brothers Corp. is a South Korean company founded in March 2011 and based in Seoul. It specializes in developing mobile applications, particularly focusing on on-demand food delivery services. The company's flagship application allows users to order and receive food deliveries within a specified timeframe, catering to their convenience. In addition to food delivery, Woowa Brothers also offers local marketing and web solutions, along with other applications like a sports events app. Through its innovative platform, the company aims to enhance the user experience in the food delivery sector and beyond.

Elpiscience Biopharmaceuticals

Series A in 2018
Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

eRoad Software

Series B in 2018
eRoad Software is a Human Resource Management Cloud Service Platform based in Shanghai, China, founded in 2004. The company specializes in providing an integrated Mobile and Employee Services platform, with a particular emphasis on payroll solutions tailored for mid-to-large sized enterprises. Its innovative "HR+ business data" model enables organizations to analyze human effectiveness and cost efficiency, thereby enhancing operational efficiency and improving business insights. The platform supports the entire employee lifecycle, encompassing functions such as recruiting, onboarding, payroll management, benefits administration, workforce management, performance management, and talent management, making it a comprehensive solution for organizations seeking to optimize their human resource processes.

Jacobio Pharmaceuticals

Series C in 2018
Jacobio Pharmaceuticals, established in 2015 in Beijing, China, is a clinical-stage biotech company specializing in the discovery and development of innovative therapies, particularly in oncology. The company aims to address unmet medical needs both in China and globally, focusing on serious diseases such as cancer, autoimmune disorders, and infectious diseases. Founded by experienced executives with a strong track record in the pharmaceutical industry, Jacobio has rapidly built a skilled research and development team of over 100 employees. This team possesses comprehensive capabilities in target discovery, medicinal chemistry, pharmacology, and clinical registration. Jacobio has developed a robust pipeline of 8 to 10 drug candidates, with JAB-3068 being the most advanced program. This candidate targets novel pathways for both immunotherapy and targeted therapies and has entered Phase I clinical trials in the United States, with additional trials planned in China.

MyDreamPlus

Series C in 2018
MyDreamPlus is a co-working space startup established in May 2015, focusing on providing a technologically advanced working environment. The company integrates space design, smart office management, and community operations to create high-quality shared office spaces. MyDreamPlus has developed an innovative management system that allows users to address various office-related tasks via their smartphones, such as unlocking doors, booking meeting rooms, and sharing Wi-Fi passwords. With over 20 locations primarily in major cities like Beijing and Chengdu, MyDreamPlus serves more than 300 enterprises, 90% of which are established companies, including notable names like COFCO, Chinese TAL Education Group, and Airbnb. The company's approach caters to a diverse clientele, including startups, freelancers, small and medium enterprises, and corporate teams, offering them a versatile and modern workspace experience.

Xpeng Motors

Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.

Xiangwushuo

Series B in 2018
Xiangwushuo is a Beijing-based company that operates an online platform for the buying and selling of unused items. It facilitates the trading of new and idle goods through a unique marketplace that employs a point system, allowing users to exchange items without the need for actual currency. In addition to individual transactions, Xiangwushuo offers business owners the opportunity to promote and sell their products online, enhancing the platform's functionality as a comprehensive marketplace for both personal and commercial goods.

Newtop100.com

Series A in 2018
Newtop100.com is a media and entertainment company based in Beijing, China, founded in 2016. It specializes in publishing news reports and conducting interviews with leaders in the new economy, focusing on innovative technologies and emerging business models. Through various audio and digital media platforms, Newtop100.com provides in-depth coverage and analysis of over 100 leading companies, allowing clients to explore investment opportunities within this dynamic sector. The company aims to highlight pioneers in different domains of the new economy, facilitating informed decisions for investors and stakeholders alike.

Moretickets

Series C in 2018
Moretickets is an online ticketing company based in Shanghai that operates a ticketing platform aimed at providing users with direct access to performance tickets. By employing a multi-channel ticket bidding mechanism, Moretickets eliminates intermediaries and offers strictly audited tickets at discounted prices. This approach allows users to obtain detailed performance information while purchasing tickets at lower costs. The company's focus on transparency and affordability distinguishes it in the competitive ticketing market.

I-Mab Biopharma

Series C in 2018
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.

Hangzhou Just Biotherapeutics

Series B in 2018
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.

Magic Ears

Series A in 2018
Magic Ears is an online teaching platform that offers English language classes specifically designed for children aged 5 to 12 in China. The company employs qualified native English-speaking teachers from America and Europe, utilizing innovative technology to deliver a natural and efficient learning experience. Through live video instruction and the use of authoritative textbooks, Magic Ears enables children to learn English in an engaging and pleasant environment, allowing teachers to focus solely on teaching.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.